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Exploring the challenges for clinical pharmacists in Sudan 
 
Introduction 
The use of the term ‘clinical pharmacy’ is thought to have flourished in the 1960s in association with 
pharmacy practice in hospital settings [1, 2].  Since the emergence of the term in the sixties, different 
definitions have been considered but all have widely shared the concept of ‘patient-oriented’ pharmacy 
service [3].  In recent years different pharmacists’ associations have provided different definitions for 
clinical pharmacy practice. For example, the term ‘clinical pharmacy’ was described by the International 
Federation of Pharmacists (FIP) as “ -the work of pharmacists whose primary job is to interact with the 
healthcare system, interview and assess patients, make specific recommendations, monitor patient 
responses to drug therapy and provide medicine information” [4].  Another definition by the American 
college of Clinical Pharmacy (ACCP) is “-a health science discipline in which pharmacists provide patient 
care that optimizes medication therapy and promotes health, wellness and disease prevention. The practice 
of clinical pharmacy embraces the philosophy of pharmaceutical care; it blends a caring orientation with 
specialized therapeutic knowledge, experience, and judgement….”[5]. Other definitions for clinical 
pharmacy by different pharmacy bodies exist which raise the question if clinical pharmacy is a speciality 
linked to pharmacy practice in certain settings, is it complementing pharmacy practice or is it the change 
that pharmacy practice had to embrace [1, 2, 6, 7].  
With regard to clinical pharmacy practice in hospitals, the role of pharmacists by the patient bedside 
has been argued  to be the only way to maintain the pharmacy profession [8]. This move towards clinical 
roles in hospitals has enhanced the concept of professionalism in pharmacy [9, 10]. A number of studies 
have examined the positive contribution of clinical pharmacists to patient care in hospitals [11-17]. 
Although the clinical role of pharmacists is well established in some countries, the defined practice of 
clinical pharmacy in hospitals is quite a new area for pharmacists in Sudan. The FIP Basel Statements on 
the future of hospital pharmacy discussed the vision of preparing and training hospital pharmacists to cover 
all areas of medicine use in the hospitals from procurement, preparation to clinical activities and 
involvement with prescribing [18].  Currently in Sudan where this study took place, clinical pharmacy in 
hospitals is considered a speciality which is only practised by pharmacists with a post graduate degree in 
clinical pharmacy. 
Pharmacists have been working in hospitals in Sudan mainly in drug supply or doing managerial roles. 
These pharmacists constitute 49% of the pharmacists working in the public sector with the majority 
working in government hospitals [19]. The Federal Ministry of Health in Sudan, which is responsible for 
the development of national health policies and strategic plans, has acknowledged the need to develop 
pharmaceutical services in hospitals [20]. With the help of the Directorate of Pharmacy, a new policy 
regarding hospital pharmacy in Sudan was included in the pharmaceutical strategic plan for the period of 
2005-2029.  Different criteria were suggested in the plan to improve hospital pharmacy practice which 
included provision of a clinical pharmacy service by training more pharmacists to become clinical 
pharmacists. 
The introduction of a Masters course in clinical pharmacy in the University of Khartoum more than 10 
years ago led to the emergence of the new title of ‘clinical pharmacist’ in hospitals in Sudan.  Accordingly, 
two different job classifications have been identified for hospital pharmacists in Khartoum hospitals during 
this study. These are clinical pharmacists, those with post graduate degree in clinical pharmacy, and non-
clinical pharmacists. This study will focus on clinical pharmacists. 
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Aim of the study 
The aim of this study was to examine the new practice of clinical pharmacy in Sudan and identify the 
challenges facing clinical pharmacists. 
Ethics Approval 
Ethical approval for this study was obtained from the National Research Ethics Committee which is 
under the Federal Ministry of Health in Khartoum, Sudan. 
Methods 
This study was exploratory in nature and hence the participants were purposively selected. These were 
the pharmacists in Sudan who have a postgraduate degree in clinical pharmacy. A sequential exploratory 
mixed method design was used. The involved a focus group discussion (FGD) with the clinical 
pharmacists in two of the main government hospitals in Khartoum followed by an online survey among the 
clinical pharmacists of Sudan. One of the two hospitals was known to the researcher to have one of the 
first qualified clinical pharmacists who undertook the post graduate clinical pharmacy course in the 
University of Khartoum.  The majority of the pharmacists in the hospitals were non-clinical pharmacists. 
Only five clinical pharmacists were identified in the two hospitals. The aim from the FGD was to provide 
the interaction between the participants which enriches the discussion [21]. The survey was meant to 
explore the issues discussed in the focus group with a larger population of clinical pharmacists.  
The FGD was conducted by the first author in August 2012. An audio-recording was carried out after 
participants’ permission was given. The FGD was conducted in a combination of the English and the 
Arabic language.  The FGD was transcribed verbatim and any part in the Arabic language was then 
translated into the English language by the first author who was familiar with the language, dialect and 
culture of the participants. This closeness of researcher to those being researched enhances the validity of 
the findings [22-24] . The translation was validated with an independent pharmacist from Sudan. 
For the survey, a list of the registered clinical pharmacists was obtained from the newly established 
Sudanese Society for Clinical Pharmacists (SSCP). The society had the e-mail addresses of 172 
pharmacists in addition to the phone numbers of 109 clinical pharmacists. The decision was thus made to 
go for an on-line survey based on the e-mail addresses available. The survey was piloted for content and 
structure with four of the clinical pharmacists from the SSCP, and for possible technical issues with the 
research supervisors in University of Bath and University of Helsinki.  
The questionnaire was designed using the University of Bristol Online Surveys (BOS) website, a free 
online survey tool available through the University of Bath. The questionnaire followed a 5-point Likert 
scale design. The survey questions were developed based on the data collected from the focus group 
discussion in addition to the literature review.  E-mail invitations were sent to the pharmacists on the 20th 
of April 2014. This was followed by a phone message reminder for those pharmacists with phone numbers 
in addition to two e-mail reminders within two and four weeks of the survey launch.  
 
Data analysis 
The FGD was analysed by presenting a descriptive summary of the data followed by interpretation of 
the data in the discussion according to Krueger (1994) methods of analysis of FGD [25].  The analysis of 
the FGD was supported by the software N_vivo 9. The conversation was coded and then grouped under 
main themes derived from the participants’ discussion or from the topic guide. For the survey the BOS 
website provided an initial descriptive analysis of the results. For further analyses, the data was transferred 
into SPSS statistics package version 20. Descriptive statistics were conducted using numbers and 
percentages to show the prevalence of the views obtained from the participants.  The Mann–Whitney test 
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was used to explore any differences in responses between the different groups of pharmacists based on 
gender and clinical hospital experience (p < 0.05).   
Results 
Of the five clinical pharmacists available in the two hospitals, four participated in the FGD. These 
pharmacists had different years of experience and were assigned to different specialities in the two 
hospitals as shown in Table 1. For the survey 24 e-mail addresses out of 172 sent came back as failed-
delivery. Therefore, based on delivered e-mail addresses 51 pharmacists out of 148 (34%) participated in 
the survey with 47 pharmacists completing all survey questions. There was participation from pharmacists 
with a wide range of years of practice based on their graduation year from pharmacy school (graduates 
from 1982 to 2010). The majority of pharmacists (92%, n =47) did their clinical pharmacy course in Sudan 
between the years 2007 and 2011. The remaining pharmacists obtained their clinical pharmacy post 
graduate degrees from universities in India, Malaysia or the UK. The survey participants’ characteristics 
are summarized in Table 2. Although 12 (24%) of the participating clinical pharmacists had no previous 
hospital experience, their views and perceptions of clinical pharmacy practice in Sudan was considered of 
relevance and hence they were included.   
The main themes identified from the FGD were the postgraduate clinical pharmacy course, the 
pharmacists’ new role and the barriers encountered in practice. In the survey the pharmacists were asked 
about their views of the current role of clinical pharmacists in Sudan and the perceived barriers to practice. 
For the pharmacists to be appointed as clinical pharmacists they had to undertake a post graduate 
course in clinical pharmacy which took two years. When the pharmacists were asked about how they knew 
what they needed to do in hospitals as clinical pharmacists, they agreed that the clinical pharmacy course 
provided them with the introduction to their new role in addition to personal effort.  
“[…] from the course we became aware of what our role will be; in addition, the second year of the 
course was spent on the wards in S…. hospital...” (Participant 2) 
“We benefited from the course, but there was also a personal effort.” (Participant 3) 
        The pharmacists considered certain areas in which the clinical pharmacy course in Khartoum was 
lacking.  One of these areas was the amount of time allocated to hospital training.   
“I think it [the course] should have been more practical than theory.” (Participant 1) 
The pharmacists also shared the view that even the hospital training had its limitations. For example, 
not having clinical pharmacists in the hospital was considered to be a setback in the course. 
“We were lost because there was no clinical pharmacist there.”(Participant 2) 
        The pharmacists had to accompany the doctors during their placement in the hospital. These doctors 
differed in their acceptance of the presence of the pharmacists and understanding of the requirements of 
their training, with some not understanding what a clinical pharmacist was supposed to do. 
“You just follow the doctor, he used to ask me, ‘who are you?’ […], ‘what do you want to do?’ […] I 
felt that I was lost […].” (Participant1)  
“There was a doctor in the unit who said I don’t want to see any pharmacist with me, […] but on the 
other hand some doctors were cooperative.”(Participant 2) 
The pharmacists in the FGD considered that their practice in hospitals has changed after being 
appointed as clinical pharmacists. Although they had been working in their hospitals before taking their 
post graduate degree in clinical pharmacy, they were based mainly in the dispensary and had no ward 
duties. 
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“A change has occurred to our job. Before, we didn’t have any contact with the wards or the doctors. 
After the clinical course we started going to ward rounds, having contact with the patient […] and with the 
doctors…” (Participant 1)  
In the survey, the majority of pharmacists considered that the different activities described for 
pharmacists were related to the role of the clinical pharmacists in hospitals in Sudan (Table 3). The main 
activities that the majority of pharmacists agreed with (either ‘strongly agree’ or ‘agree) were for the 
clinical pharmacist to identify drug-related problems (100%, n=49), to provide drug-related information to 
healthcare professionals 96% (47) and to educate patients about their medicines (96%, n=48). 
 In the FGD the pharmacists considered the acceptance by doctors of their new role as one of the 
challenges facing their practice. 
“Although it has been four years since I started to be part of the ward rounds, the doctors don’t think 
that I should be part of that and intervene and contribute to the treatment plan, as if all what I am doing is 
purely a voluntary work from my side, that is, an extra thing above of what is required from the 
pharmacist.” (Participant 2) 
The pharmacists also considered that the lack of easy access to information sources and absence of 
national guidelines was hindering their practice. 
If you need any information about something, you want a book, internet; we have to pay from our 
own money’.”(Participant 1) 
“There are no national guidelines; this part of the doctor’s experience has got a big role in therapy 
[…], some doctors will tell you that the international guidelines belongs to foreign countries, it does not 
apply to us.”(Participant 2) 
Although the clinical pharmacists were appointed as specialist pharmacists, different to the other 
pharmacists in the hospital, there was still no agreed job description for a clinical pharmacist. 
“Also one of the obstacles which may be clear from the beginning, is that there is no job 
description.”(Participant 2) 
Lack of enough clinical pharmacists in the hospitals also made it difficult for pharmacists to cover all 
patients as only one clinical pharmacist was appointed to each speciality. 
“We have got six units; it is difficult to cover the six.”(Participant 1) 
The pharmacists were concerned that their managers were not aware of their need for continuous 
professional development (CPD) and although they gave them the chance to do the clinical pharmacy 
course, this was not enough and further support was required. 
“We just started knowing how to practice clinical pharmacy, but there is no support for continuous 
training.”(Participant 4) 
In the survey that followed the pharmacists either agreed or strongly agreed that the main barriers 
affecting clinical pharmacy practice were the lack of experience in applying the clinical knowledge 
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acquired to practice (94%, n=46), the unavailability of senior clinical pharmacists (90%, n=43) and the 
lack of opportunities for continuous professional development (98%, n=46). The details of these results are 
shown in Table 4. 
In the survey 68 % (34) of pharmacists did not consider that limited support from doctors to be an 
obstacle for clinical pharmacists. However, 59% (27) considered that there was resistance from doctors to 
pharmacists’ involvement in prescribing.  
 There was a split between pharmacists’ views with regard to pharmacists themselves being resistant to 
change.  While 48% (24) found this not to be true, 40% (20) were in agreement with this statement. A 
large number of pharmacists 65% (31) either ‘agreed’ or ‘’strongly agreed’ that lack of confidence is 
affecting clinical pharmacy practice. 
      The absence of national guidelines as mentioned by one of the participants in the FGD was perceived 
by 80 % (37) of the pharmacists as affecting their practice. In addition, 40 % (19) of pharmacists felt that 
the use of international guidelines by prescribers as a barrier to their practice. 
       Using the Mann-Whitney test, a statistically significant difference in response was found between 
participants with regard to whether or not they had previous hospital clinical experience. Pharmacists with 
hospital clinical experience were more likely to agree than those with no clinical experience that there 
were not enough clinical pharmacists in hospitals (U = 136, p= 0.037).  Furthermore, male pharmacists 
were more likely to agree than females that a lack of confidence from pharmacists was creating a barrier to 
practice (U = 104, p = 0.001).  
 
Discussion 
This mixed method study which was conducted within a period of two years from August 2012 to 
April 2014 investigated the new practice of clinical pharmacy in Sudan. The study found that hospital 
pharmacists felt a shift has occurred in their professional status since they became clinical pharmacists but 
there are a number of challenges facing clinical pharmacy practice.  
The majority of pharmacists when presented with different duties related to clinical pharmacy 
practice expected clinical pharmacists in hospitals in Sudan to be performing most of these duties. There 
were roles which achieved an overall agreement by pharmacists as being part of the clinical pharmacist’s 
job. These were identifying drug related problems (100%, n=49) and educating patients about their 
medicines (96%, n=48). There was also a wide acceptance from pharmacists that their role in hospitals 
involved participation with prescribers in providing optimum therapy.  
With regard to the barriers facing pharmacists, these can be divided into two groups. The first group 
was about pharmacists themselves being the barrier to role change.  Some of the pharmacists perceived 
that personal characteristics such as a lack of confidence (65%, n=31) and an attitude which is resistant to 
change (40%, n=20) as challenges to clinical pharmacy practice.  The argument that pharmacists’ attitudes 
have prevented them from making role changes was previously discussed [26-28]. The claim was that the 
key constraint to the advancement of clinical pharmacy practice was due to more than just external factors 
such as resistance from the doctors or lack of enough pharmacists. The main obstacle was seen to be the 
pharmacy culture itself which is resistant in shifting from the ‘comfortable zone’ of drug focused practice 
to the ‘unknowns’ of the patient centred practice.  However, the expectation is that as more skills are 
acquired, pharmacists in Sudan will be able to overcome these personal barriers. 
The second group of barriers included external factors such as not having senior clinical pharmacists 
or having prescribers resistant to pharmacist involvement. Interestingly (68%, n=34) of the pharmacists in 
this survey did not perceive the lack of support from doctors as a barrier to practice. Whether this means 
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that the doctors were supporting them or their support was not required is unknown. However, more than 
half of the participants (59%, n=27) considered that doctors’ resistance to pharmacists getting involved in 
prescribing as a challenge to clinical pharmacy practice. This resonates with previous findings that 
prescribers may be less comfortable with advanced roles for pharmacists such as recommending 
prescription drugs [29-33]. 
The lack of senior clinical pharmacists in hospitals who can support new clinical pharmacists was 
seen as one of the major challenges in practice.  Being a new area of practice in Sudan, current clinical 
pharmacists need to consider themselves as the leaders of the new practice, especially as a large number of 
those who did the clinical pharmacy course had previous hospital work experience. The leaders of clinical 
pharmacy practice around the world have been pharmacists who were working in hospitals but made the 
shift from being pharmacy based to being available on the wards [1, 34]. 
The pharmacists were also challenged by the absence of national guidelines and the lack of access to 
information.  In a study in Jordan, limited access to information sources was identified by pharmacists as 
making them less able of ensuring evidence-based prescribing (35). Furthermore, the pharmacists felt that 
the lack of continuous professional development was hindering their practice. Despite limited resources 
pharmacists may need to take the initiative themselves and find suitable ways to undertake CPD. It is 
hoped that the recent efforts by the SSCP to organize training sessions in different areas of clinical care 
may be a starting point for pharmacists for professional development. However, the Society needs to 
consider that pharmacists not only require more clinical knowledge but also need to develop certain skills 
for example communication skills in order to be able to transfer their clinical knowledge to practice. 
The survey found that half of the participants who were clinical pharmacists were not actually 
working in hospitals. The actual cause for that is unknown but one reason may be that the rate of pay in 
hospitals, which was perceived as a barrier to clinical pharmacy practice, was low and hence pharmacists 
felt that their qualification was unrewarded. Furthermore, there may not be enough ‘clinical pharmacist’ 
jobs compared to non-clinical jobs in hospitals. It may also be a personal decision from the pharmacists 
that although they acquired the clinical post-graduate degree, they do not necessarily link that with hospital 
work. 
There are currently two tiers of pharmacists in Sudan, clinical and non-clinical pharmacists. Only 
clinical pharmacists are expected to have ward duties.  The concern regarding two tiers of pharmacists was 
previously raised in that it allows different levels of services to be provided by pharmacists [36].  This can 
create confusion among the public and healthcare professionals about what service to expect from 
pharmacists which is not in favour of the profession. However, the undergraduate pharmacy courses in 
Sudan were perceived as not providing the required clinical training [37].  Some of the participating 
pharmacists identified the need for a less theoretical and more clinical approach to pharmacists’ training. 
The latter has been discussed in previous studies where the emphasis on a change in pharmacy teaching 
was perceived to be the main element in creating competent pharmacists [1, 2,  9, 10].  
It has been argued that pharmacists alone cannot advance without the support of the government and 
the healthcare institutions in which they are practicing [2, 38, 39]. This support whether in the form of 
training or availability of resources was considered by some of the pharmacists in this study to be a 
requirement for progress. The Federal Ministry of Health in Sudan supported the call for improvement of 
hospital pharmaceutical services to meet future challenges [20]. However, as pharmacy is only one issue 
out of many concerns facing the healthcare system, it may be a while before the health authorities will 
have the resources to put into clinical pharmacy practice in Sudan.  
The pharmacists in this study perceived that their practice was affected by a lack of a job description. 
Although the majority of the pharmacists seemed to agree with the different roles identified for hospital 
clinical pharmacists, one can understand the uncertainty these pharmacists were facing in deciding to what 
extent this new ‘clinical’ identity would allow them to intervene in patient management. Considering the 
changes that are either advocated for pharmacy practice or those which have already taken place, there is a 
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need to identify the exact role of the pharmacist of today [40].  The argument is that unless the exact role 
of the pharmacist is acknowledged, pharmacists will struggle to get the recognition for their new clinical 
identity. However, the assumption that there is a one model for clinical pharmacy practice that fits all may 
be far from realistic. Although some pharmacy bodies in different countries especially those with advanced 
clinical pharmacy practice may have set descriptions and standards for clinical practice, these may not fit 
with the practice in Sudan. There is no doubt that there is a need for standards for practice. However, 
clinical pharmacists together with pharmacy regulating bodies in Sudan need to set the standards and the 
job specification for practice that suit the patient and the healthcare system of the country.  
As with all studies using self-report it is not known whether the actual responses reflect the true 
behaviour of the participant. Measures such as anonymity and confidentiality were used to minimize 
effects like social-desirability bias. The findings were based on the results obtained from the pharmacists 
who responded to the questionnaire. It is not known if those who did not respond would have a different 
perspective of the issues explored in the survey. 
Conclusion 
The practice of clinical pharmacy in hospitals in Sudan can be considered to be in its preliminary 
stages of development. Clinical pharmacists in Sudan have experienced barriers in their practice that they 
need to overcome in order that patients can benefit from their drug knowledge. It is also of importance that 
for clinical pharmacists to take their desired professional place, pharmacy academics, healthcare 
professionals as well as healthcare mangers need to be involved to support the transition. 
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Table 1   Characteristics of the participants in the Focus Group Discussion 
 
 
 
 
Table 2   Characteristics of the survey participants (N=51) 
 % OF PARTICIPANTS NUMBER OF PARTICIPANTS 
Gender   
Male 29 15 
Female 71 36 
Years since graduation   
0-5 9 4 
6-10 30 14 
>10 62 29 
Number of years since clinical pharmacy 
course 
  
0-5 72 36 
6-10 26 13 
>10 2 1 
Country where clinical pharmacy course 
was taken 
  
Sudan 92 47 
Abroad 8 4 
Currently hospital clinical pharmacist   
Yes 51 26 
No 49 25 
Previous hospital experience (for those 
who were not working in hospitals) 
  
Yes 26 13 
No 24 12 
 
 
 
 
 
 
PARTICIPANT 
 CODE NAME 
SEX HOSPITAL COUNTRY 
WHERE 
MASTERS  IN 
CLINICAL 
PHARMACY WAS 
OBTAINED 
YEARS OF 
PRACTICE AS 
CLINICAL 
PHARMACIST 
Participant 1 Female Hospital 1 Sudan 2 
Participant 2 Female Hospital 2 Sudan 5 
Participant 3 Female Hospital 1          Sudan 4 
Participant 4   Male Hospital 2 Malaysia 4 
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Table 3   Role of the clinical pharmacist in hospitals in Sudan (N=50) 
 STRONGLY 
DISAGREE% 
(N) 
DISAGREE NEITHER 
AGREE 
NOR 
DISAGREE 
AGREE STRONGLY 
AGREE 
 
Provide drug  
related information 
 
 
2(1) 
 
2(1) 
 
- 
 
22(11) 
 
74(37) 
Educate patients 
about their 
medicines 
 
- - 4(2) 18(9) 78(39) 
Identify drug 
related problems 
 
- - - 27(13) 74(36) 
Assist doctors in 
prescribing drugs 
 
- 2(1) 15(7) 28(13) 55(26) 
Provide drug 
related information 
mainly to doctors 
 
6(3) 12(6) 14(7) 37(18) 31(15) 
Inform doctors 
about availability of 
drugs 
 
2(1) 8(4) 10(5) 39(19) 41(20) 
Inform doctors 
about therapy 
guidelines 
 
- 6(3) 12(6) 31(15) 51(25) 
Take drug histories 
of  patients 
admitted 
 
- 10(5) 6(3) 38(18) 46(22) 
Inform doctors 
about cost effective 
medications 
 
2(1) 4(2) 20(10) 38(19) 28(14) 
Provide drug 
information mainly 
to patients 
 
8(4) 14(7) 12(6) 38(19) 28(14) 
Participate in 
clinical-care 
meetings 
 
2(1) 2(1) 4(2) 35(17) 57(28) 
Ensure prescribers 
are providing 
optimum therapy 
 
- 2(1) 8(4) 27(13) 63(31) 
To be involved in 
doctors’ choices of 
medicines 
- 8(4) 14(7) 24(12) 54(27) 
         (-): no participant chose this answer 
12 
 
 
 
Table 4   Barriers affecting clinical pharmacy practice in hospitals in Sudan (N=50) 
Statement Strongly 
disagree 
%(N) 
Disagree 
%(N) 
Neither 
agree nor 
disagree 
% (N) 
Agree 
%(N) 
Strongly agree 
%(N) 
Lack of information sources 12(6) 20(10) 10(5) 40(20) 18(9) 
Pharmacists’ resistance to 
change 
 
18(9) 30(15) 12(6) 30(15) 10(5) 
Limited support from doctors 
 
32(16) 36(18) 14(7) 12(6) 6(3) 
Lack of confidence 
 
2(1) 15(7) 19(9) 46(22) 19(9) 
Hospital payment 
 
4(2) 20(10) 6(3) 32(16) 38(19) 
Doctors following 
‘international’ guidelines 
 
2(1) 21(10) 38(18) 38(18) 2(1) 
Unavailability of ‘national’  
guidelines 
 
- 11(5) 9(4) 52(24) 28(13) 
Lack of experience of applying 
clinical knowledge to practice 
 
2(1) 4(2) - 47(23) 47(23) 
More concern with doctors’ 
approval than performing the 
job 
 
4(2) 21(10) 15(7) 46(22) 15(7) 
Resistance from doctors to 
pharmacists involvement in 
prescribing 
 
4(2) 20(9) 17(8) 35(16) 24(11) 
Lack of CPD opportunities 
 
- 2(1) - 40(19) 57(27) 
No senior clinical pharmacists 
 
2(1) 2(1) 6(3) 23 (11) 67(32) 
No job description for ‘clinical 
pharmacist’ 
 
4(2) 6(3) 6(3) 45(21) 38(18) 
Lack of communication skills 
 
8(4) 35(17) 17(8) 38(18) 2(1) 
Not enough clinical pharmacists 
in the hospital 
 
2(1) 4(2) 6(3) 43(21) 45(22) 
(-): no participant chose this answer 
 
 
 
